Drawing for ADAVIUM

USPTO serial 86964535

ADAVIUM

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
SALCIDO, JOHN CHARLES
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with ADAVIUM?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

John A. Galbreath

JOHN A. GALBREATH GALBREATH LAW OFFICES, P.C.2516 CHESTNUT WOODS CT.REISTERSTOWN, MD 21136UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
003Cosmetic products, namely, cream, lotion, gel cream, shampoo, soaps, detergent, exfoliants, astringent, depilatory cream, non-medicated cosmetics for cleaning and general treatment of skin, non-medicated acne treatment preparations, facial cleaning preparations, namely, salicylic acne cleanser not for medical purposes, non-medicated dermatological creams and lotions for the skin; Cleaning preparations for medical ventilator equipment, tubing, and masksACTIVE—
005Dermatologicals, Dermatological pharmaceutical products; Medical, pharmaceutical, and veterinary preparations, namely, medical diagnostic reagents; Products and systems for in vitro diagnostic use, intended for clinical medical and medical diagnostic purposes, namely, reagents for autoimmunity and allergy biochemistry calibrators and controls, electrophoresis, hematology, immunology by ELISA, hemostasis, latex agglutination testing, fast testing, turbidimetry, blood typology, urinalysis, immunology, proteins analysis or stabilization, detection of human hormones and tumor markers, mycology, gastric panels, parasitology, retroviruses, and detection of certain toxins for diagnostic and medical purposes, latex reagents, protein arrays for medical purposes, hormones, and diagnostic biomarker reagents for medical purposes; Diagnostic reagents and preparations for medical purposes for qualitative and quantitative detection of infectious agents to virology, bacteriology and coagulation factors; Washing solutions for equipment, namely, detergents for medical purposes and sanitary sterilizing preparations; Enzymes for medical purposes; Vitamins; Immunofluorescence reagents for medical use; Chemical preparations for histocompatibility testing for medical use; Medical diagnostic preparations and chemical reagents for use in flow cytometry and immunohistochemistry; Biological sample collection and storage containers sold prefilled with reagents for medical use; Diagnostic preparations for medical use, namely, diagnostic preparations for carrying out complement fixation and western blot tests for medical purposes; Sanitary preparations for medical use, namely, general surgery, urology, gynecology, otolaryngology, dermatology, ophthalmology, plastic surgery and vascular surgeryACTIVE—
010Medical devices and equipment for use in medicine, namely, appliances and equipment for the reduction of localized fat and reduction in underarm sweat; automated diagnostic systems used to generate diagnostic tests results for medical purposes; plate washers, plates readers, and incubators for medical purposes; ELISA methodology automated equipment for medical diagnostic purposes; automated analyzers for analyzing immunoassays using magnetic microparticles for medical diagnostic purposes; automated equipment for immunofluorescence tests and chemiluminescence for medical diagnostic purposes; biochemistry analyzer, hematology analyzer, and coagulometric analyzer for medical diagnostic purposes; equipment for chromogenic and immunological testing for medical diagnostic purposes; medical instruments comprising of gas, electrolytes, glucose, lactate and co-oximetry analyzers; Activated Clotting Time (ACT) analyzer; medical equipment and devices for electrophoresis by agarose gel method and capillarity method; medical apparatus for reduction of localized fat by LASER lipolysis, liposuction technology and criolipolysis; medical apparatus for reducing sweat in the armpits; LASER devices, light, and radiation emission instruments, namely, microwaves, ultrasound and radiofrequency for medical treatment of acne, scars, stretch marks, hair removal, removal of natural and artificial pigments, skin tightening, collagen stimulation, and skin rejuvenation, discrete vascular lesions, and varicose veins; medical apparatus for treatment of soft tissue, with or without contact, during surgical procedures; medical apparatus for the incision, excision, vaporization, ablation, hemostasis or coagulation of soft tissue procedures during general surgery, urology, gynecology, otolaryngology, dermatology, ophthalmology, plastic surgery and vascular surgery; Orthopedic articles, namely, bone prostheses, joint prostheses, hip prostheses, and orthotics for feet and hands; Suture materials; Medical equipment for applications in opthalmology, vascular surgery, and urology; Products for blood banks, namely, blood bags and blood transfusion apparatus; Video recorders for recording medical surgery; Products and systems for in vitro diagnostic use, intended for clinical medical and medical diagnostic purposes, namely, medical diagnostic instruments for the qualitative and quantitative detection of infectious agents to virology, bacteriology and coagulation factors; Medical apparatus for use in immunofluorescence analysis; Diagnostic apparatus for medical use, namely, flow cytometers and automatic cell sorting systems for use in flow cytometry analysis; immunohistochemistry analyzers for medical diagnostic uses; Biological sample collection and transport kits, namely, medical sample tubes with media formulations for use in collecting, preserving stability, and transport of biological samples for medical diagnostic testing, for medical purposesACTIVE—
035Import and export agency services in the nature of medical apparatus and equipment for use in medicine, namely, appliances and equipment for the reduction of localized fat, reduction in underarm sweat, Automated Diagnostic Systems, plate washer, plates reader, plates Incubator, ELISA methodology automated equipment, automated analyzers for methodology HALF magnetized (immunoassay using magnetic microparticles), automated equipment for immunofluorescence tests and chemiluminescence, reconditioning parts, parts and equipment, biochemistry analyzer, hematology analyzer, analyzer coagulometric, chromogenic and immunological testing, gas analyzer, electrolytes, glucose, lactate and co-oximetry, analyzer ACT (Activated Clotting Tempode), equipment for electrophoresis by agarose gel method, equipment for electrophoresis methodology by capillarity, equipment for electrophoresis methodology by capillarity, apparatus for reduction of localized fat by means of LASER lipolysis, liposuction technology and criolipolysis, apparatus for reducing sweat in the armpits, LASER devices, light and other sources of radiation and emission of energy, such as microwaves, ultrasound and radiofrequency, for medical areas, namely, treatment of acne, scars, stretch marks, hair removal, removal of natural and artificial pigments, skin tightening, collagen stimulation and skin rejuvenation in general, as well as discrete vascular lesions, superficial in the face or lower limbs through sclerotherapy and cryo-sclerotherapy, LASER and associated technologies, varicose veins, LASERs, fittings, systems and technologies for treatment of soft tissue, with or without contact, during surgical procedures, including those using endoscopes, catheters or introducers, LASERs, accessories, systems and technologies for the incision, excision, vaporization, ablation, hemostasis or coagulation of soft tissue procedures linked directly or indirectly to the general surgery, urology, gynecology, otolaryngology, dermatology, ophthalmology, plastic surgery and vascular surgeryACTIVE—
039Supply chain logistics and reverse logistics services, namely, packaging, storage, and distribution of products for in vitro diagnostics, pharmaceuticals, and medical diagnostic sterile equipment and devices for others by air, rail, ship, or truckACTIVE—
042Product development; Research and development of equipment for medical purposes; Technical assistance services in the nature of diagnosing computer hardware and software problems in the field of medical devices and equipment; Technical support services, namely, troubleshooting in the nature of diagnosing problems with medical automatic diagnostic systems; Laboratory research services in the field of in vitro diagnostics; Engineering services in the field of in vitro diagnostic equipment, namely, evaluations, research and reports in scientific and technological fields; Scientific research for medical purposes; Scientific and technological services, namely, research, testing, and design in the field of in vitro diagnostics; Industrial analysis and research services in the field of in vitro diagnosticsACTIVE—
044Medical clinic services; Medical testing for diagnostic or treatment purposes; Medical diagnostic testing for use in clinical trials in the in-vitro diagnostics industriesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
May 7, 2018MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
May 7, 2018ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Oct 3, 2017NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Aug 8, 2017NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Aug 8, 2017PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 19, 2017NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jul 11, 2017DOCKASSIGNED TO EXAMINER—
Jul 6, 2017PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Jun 19, 2017CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 16, 2017TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 16, 2017CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 16, 2017TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 14, 2017GPRNNOTIFICATION OF PRIORITY ACTION E-MAILEDA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Apr 14, 2017GPRAPRIORITY ACTION E-MAILEDA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Apr 14, 2017CPRAPRIORITY ACTION WRITTENA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Apr 7, 2017ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
Apr 4, 2017PBCRWITHDRAWN FROM PUB - OG REVIEW QUERY—
Mar 20, 2017PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Mar 9, 2017CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 9, 2017XAECEXAMINER'S AMENDMENT ENTERED—
Mar 9, 2017GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Mar 9, 2017GNEAEXAMINERS AMENDMENT E-MAILED—
Mar 9, 2017CNEAEXAMINERS AMENDMENT -WRITTEN—
Mar 8, 2017XAECEXAMINER'S AMENDMENT ENTERED—
Mar 8, 2017GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Mar 8, 2017GNEAEXAMINERS AMENDMENT E-MAILED—
Mar 8, 2017CNEAEXAMINERS AMENDMENT -WRITTEN—
Feb 1, 2017TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Feb 1, 2017CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 25, 2017ALIEASSIGNED TO LIE—
Jan 6, 2017TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 28, 2016GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 28, 2016GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 28, 2016CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 20, 2016DOCKASSIGNED TO EXAMINER—
Apr 8, 2016NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 8, 2016NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance